_id

69105cdbccc777a4e85d5881

Ticker

DRMA

Name

Dermata Therapeutics Inc

Exchange

NASDAQ

Address

3525 Del Mar Heights Rd., San Diego, CA, United States, 92130

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.dermatarx.com

Description

Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its lead product candidate is XYNGARI, which is in Phase 3 clinical studies for the treatment of moderate-to-severe acne, as well as completed Phase 1b proof of concept (POC) trial for mild-to-moderate psoriasis. The company is also developing DMT410 that has completed Phase 1b POC trials for the treatment of axillary hyperhidrosis and aesthetic skin conditions. It has a clinical trial collaboration agreement with Revance Therapeutics, Inc. to conduct a multi-center clinical trial to evaluate the topical application of XYNGARI with DAXXIFY, Revance's botulinum toxin type A. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Last Close

2.75

Volume

8575

Current Price

2.63

Change

-4.363636363636368

Last Updated

2025-11-29T12:22:41.284Z

Image

data:image/webp;base64,UklGRsAAAABXRUJQVlA4ILQAAADwBwCdASpAAEAAPqFGm0mmJCKhOfdoAMAUCWgAzb4g/metG8U3gIv/2wLf/AW7WXlpYIgfs4flEPPGWmEMFJ7zOnYjlWPI1EAA/tLGP2w4lSVofiO5ADuT1qgPqlYLlMZFLDcJmYSQBAM9gb1WyMb+TqBsggGh1cGwdxyjsqXTm/qHgx42Dnlb+0gHPVQ5z92a4kqFI6O7dZPvftAyI2bJPt+wTA6Gr+kLjteeRLzAmsAAAAA=

Ipo Date

2021-08-13T00:00:00.000Z

Market Cap

3223075

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.318

Sentiment Sources

1

Rating

4

Target Price

10

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

1760671

Operating Income

-1760671

Interest Expense

-

Pretax Income

-1691989

Net Income

-1691989

Eps

-1.6483778667786375

Dividends Per Share

-

Shares Outstanding

1026457

Income Tax Expense

-

EBITDA

-1691989

Operating Margin

-

Total Other Income Expense Net

68682

Cash

4664127

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

5071410

Property Plant Equipment

-

Total Assets

5071410

Payables

453427

Short Term Debt

-

Long Term Debt

-

Total Liabilities

1111308

Equity

3960102

Depreciation

-

Change In Working Capital

-149667

Cash From Operations

-1803815

Capital Expenditures

5

Cash From Investing

-

Cash From Financing

-12988

Net Change In Cash

-1816803

PE

0.206

PB

0.6816950447235955

ROE

-42.725894434032256

ROA

-33.36328555569359

FCF

-1803820

Fcf Percent

-

Piotroski FScore

0

Health Score

41

Deep Value Investing Score

9

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

6

Quality Investing Score

3

Value Investing Score

9.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

1760671

Quarters > 0 > income Statement > operating Income

-1760671

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-1691989

Quarters > 0 > income Statement > net Income

-1691989

Quarters > 0 > income Statement > eps

-1.6483778667786375

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

1026457

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-1691989

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

68682

Quarters > 0 > balance Sheet > cash

4664127

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

5071410

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

5071410

Quarters > 0 > balance Sheet > payables

453427

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

1111308

Quarters > 0 > balance Sheet > equity

3960102

Quarters > 0 > cash Flow > net Income

-1691989

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

-149667

Quarters > 0 > cash Flow > cash From Operations

-1803815

Quarters > 0 > cash Flow > capital Expenditures

5

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-12988

Quarters > 0 > cash Flow > net Change In Cash

-1816803

Quarters > 0 > ratios > PE

-1.6483778667786375

Quarters > 0 > ratios > PB

0.6816950447235955

Quarters > 0 > ratios > ROE

-42.725894434032256

Quarters > 0 > ratios > ROA

-33.36328555569359

Quarters > 0 > ratios > FCF

-1803820

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

41

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

1772731

Quarters > 1 > income Statement > operating Income

-1772731

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-1701093

Quarters > 1 > income Statement > net Income

-1701093

Quarters > 1 > income Statement > eps

-1.6571681022809415

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

1026506

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-1701093

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

71638

Quarters > 1 > balance Sheet > cash

6480930

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

6480930

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

6640516

Quarters > 1 > balance Sheet > payables

413687

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

1026265

Quarters > 1 > balance Sheet > equity

5614251

Quarters > 1 > cash Flow > net Income

-1701093

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-1028621

Quarters > 1 > cash Flow > cash From Operations

-2690481

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-547857

Quarters > 1 > cash Flow > net Change In Cash

-3238338

Quarters > 1 > ratios > PE

-1.6571681022809415

Quarters > 1 > ratios > PB

0.480867488824422

Quarters > 1 > ratios > ROE

-30.29955376059959

Quarters > 1 > ratios > ROA

-25.616879772595986

Quarters > 1 > ratios > FCF

-2690481

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

41

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

2339803

Quarters > 2 > income Statement > operating Income

-2339803

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-2303587

Quarters > 2 > income Statement > net Income

-2303587

Quarters > 2 > income Statement > eps

-4.468645974781765

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

515500

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-2303587

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

36216

Quarters > 2 > balance Sheet > cash

9719268

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

10005007

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

10005007

Quarters > 2 > balance Sheet > payables

1395313

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

2703785

Quarters > 2 > balance Sheet > equity

7301222

Quarters > 2 > cash Flow > net Income

-2303587

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

332332

Quarters > 2 > cash Flow > cash From Operations

-1934066

Quarters > 2 > cash Flow > capital Expenditures

4

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

8491764

Quarters > 2 > cash Flow > net Change In Cash

6557698

Quarters > 2 > ratios > PE

-4.468645974781765

Quarters > 2 > ratios > PB

0.18569014885453422

Quarters > 2 > ratios > ROE

-31.550704799826658

Quarters > 2 > ratios > ROA

-23.02434171210475

Quarters > 2 > ratios > FCF

-1934070

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

3200288

Quarters > 3 > income Statement > operating Income

-3200288

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-3150938

Quarters > 3 > income Statement > net Income

-3150938

Quarters > 3 > income Statement > eps

-20.26326688102894

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

155500

Quarters > 3 > income Statement > income Tax Expense

3204000

Quarters > 3 > income Statement > EBITDA

-3150938

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

49350

Quarters > 3 > balance Sheet > cash

3161570

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

3533888

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

3533888

Quarters > 3 > balance Sheet > payables

808011

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

1972794

Quarters > 3 > balance Sheet > equity

1561094

Quarters > 3 > cash Flow > net Income

-3150938

Quarters > 3 > cash Flow > depreciation

3200000

Quarters > 3 > cash Flow > change In Working Capital

207509

Quarters > 3 > cash Flow > cash From Operations

-2913614

Quarters > 3 > cash Flow > capital Expenditures

4

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-68568

Quarters > 3 > cash Flow > net Change In Cash

-2982182

Quarters > 3 > ratios > PE

-20.26326688102894

Quarters > 3 > ratios > PB

0.261973334084943

Quarters > 3 > ratios > ROE

-201.84165719681198

Quarters > 3 > ratios > ROA

-89.16349357987576

Quarters > 3 > ratios > FCF

-2913618

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

32

Valuation > metrics > PE

0.206

Valuation > metrics > PB

0.6816950447235955

Valuation > final Score

90

Valuation > verdict

64.9% Undervalued

Profitability > metrics > ROE

-42.725894434032256

Profitability > metrics > ROA

-33.36328555569359

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.28062610508517205

Risk > final Score

80

Risk > verdict

Low

Liquidity > metrics > Current Ratio

11.184622883066073

Liquidity > metrics > Quick Ratio

11.184622883066073

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

80

Prev Risks > 1

80

Prev Risks > 2

50

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:24:04.860Z